ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers

Conjupro Biotherapeutics, Inc. · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
gastric-cancerpancreatic-cancer
pancreatic cancer, gastric cancer, claudin 18.2 adc, phase 1, cpo102, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 853918
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.